COVID-19 in people living with diabetes: An international consensus.
COVID-19
COVID-19 and diabetes
Consensus
Diabetes
Diabetes complications
Diabetes management
Journal
Journal of diabetes and its complications
ISSN: 1873-460X
Titre abrégé: J Diabetes Complications
Pays: United States
ID NLM: 9204583
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
29
06
2020
accepted:
29
06
2020
pubmed:
12
7
2020
medline:
28
8
2020
entrez:
12
7
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic has added an enormous toll to the existing challenge of diabetes care world-wide. A large proportion of patients with COVID-19 requiring hospitalization and/or succumbing to the disease have had diabetes and other chronic conditions as underlying risk factors. In particular, individuals belonging to racial/ethnic minorities in the U.S. and other countries have been significantly and disproportionately impacted. Multiple and complex socioeconomic factors have long played a role in increasing the risk for diabetes and now for COVID-19. Since the pandemic began, the global healthcare community has accumulated invaluable clinical experience on providing diabetes care in the setting of COVID-19. In addition, understanding of the pathophysiological mechanisms that link these two diseases is being developed. The current clinical management of diabetes is a work in progress, requiring a shift in patient-provider interaction beyond the walls of clinics and hospitals: the use of tele-medicine when feasible, innovative patient education programs, strategies to ensure medication and glucose testing availability and affordability, as well as numerous ideas on how to improve meal plans and physical activity. Notably, this worldwide experience offers us the possibility to not only prepare better for future disasters but also transform diabetes care beyond the COVID-19 era.
Identifiants
pubmed: 32651031
pii: S1056-8727(20)30433-5
doi: 10.1016/j.jdiacomp.2020.107671
pmc: PMC7336933
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
107671Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Diabetes Care. 2005 Sep;28(9):2305-11
pubmed: 16123509
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Diabetes Res Clin Pract. 2017 Apr;126:303-316
pubmed: 28347497
Diabetes Care. 2009 Sep;32(9):1632-8
pubmed: 19542210
BMJ. 2020 Apr 14;369:m1483
pubmed: 32291262
N Engl J Med. 2020 Aug 20;383(8):789-790
pubmed: 32530585
J Clin Endocrinol Metab. 2020 Sep 1;105(9):
pubmed: 32498085
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
J Diabetes Sci Technol. 2020 Jul;14(4):822-832
pubmed: 32536205
Diabetes Res Clin Pract. 2018 Oct;144:213-223
pubmed: 30179683
BMJ. 2020 Apr 20;369:m1548
pubmed: 32312785
J Diabetes. 2020 Jul;12(7):556-557
pubmed: 32419360
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):917-920
pubmed: 32574982
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):577-578
pubmed: 32416526
Diabetes Res Clin Pract. 2020 Jul;165:108267
pubmed: 32533988
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):949-952
pubmed: 32604013
Diabetes Care. 2006 Jan;29(1):158-60
pubmed: 16373918
J Diabetes Sci Technol. 2014 Sep;8(5):930-6
pubmed: 25125454
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):273-276
pubmed: 32283497
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
Diabetes Care. 2020 Jul;43(7):1427-1432
pubmed: 32409501
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):757-759
pubmed: 32504992
Am J Trop Med Hyg. 2020 Jul;103(1):69-72
pubmed: 32446312
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212
pubmed: 32172175
Diabetes Obes Metab. 2020 Oct;22(10):1951-1952
pubmed: 32463166
Diabetes Res Clin Pract. 2020 May;163:108186
pubmed: 32360400
Am J Prev Med. 2020 Jul;59(1):137-139
pubmed: 32430225
Endocr Pract. 2019 Jul;25(7):766-768
pubmed: 31298951
Diabet Med. 2006 Jun;23(6):623-8
pubmed: 16759303
Rev Saude Publica. 2020;54:54
pubmed: 32491053
Diabetes Care. 2020 Jul;43(7):1408-1415
pubmed: 32430456
BMJ Open Diabetes Res Care. 2020 Apr;8(1):
pubmed: 32345579
J Clin Endocrinol Metab. 2020 Aug 1;105(8):
pubmed: 32474598
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Diabetes Res Clin Pract. 2020 May;163:108151
pubmed: 32305399
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):319-323
pubmed: 32298984
Endocr Rev. 2020 Jun 1;41(3):
pubmed: 32294179
Diabetes Care. 2007 Sep;30(9):2395-8
pubmed: 17623820
J Clin Virol. 2020 Jun;127:104354
pubmed: 32305882
Lancet Respir Med. 2020 Apr;8(4):e21
pubmed: 32171062
Endocrine. 2020 Apr;68(1):2-5
pubmed: 32279224
Diabetes Metab. 2020 Sep;46(4):265-271
pubmed: 32447101
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):303-310
pubmed: 32298981